Pierre, N., VIEUJEAN, S., Meuwis, M.-A., & Louis, E. (2023). Définir la rémission biologique dans la maladie de Crohn. Medi-Sphere. |
Pierre, N., Vieujean, S., Peyrin-Biroulet, L., Meuwis, M.-A., & Louis, E. (2023). Defining biological remission in Crohn's disease: interest, challenges and future directions. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjad086 |
Vieujean, S., & Louis, E. (2023). Precision Medicine and Drug Optimization in Adults Inflammatory Bowel Disease Patients. Therapeutic Advances in Gastroenterology. doi:10.1177/17562848231173331 |
Vieujean, S., Caron, B., Haghnejad, V., Jouzeau, J.-Y., Netter, P., Heba, A.-C., Ndiaye, N. C., Moulin, D., Barreto, G., Danese, S., & Peyrin-Biroulet, L. (09 July 2022). Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models. International Journal of Molecular Sciences, 23 (14), 7611. doi:10.3390/ijms23147611 |
VIEUJEAN, S., Caron, B., Jairath, V., Benetos, A., Danese, S., LOUIS, E., & Peyrin-Biroulet, L. (22 May 2022). Is it time to include older adults in inflammatory bowel disease trials? A call for action. The Lancet Healthy Longevity, 3 (5), 356 - e366. doi:10.1016/S2666-7568(22)00060-5 |
VIEUJEAN, S. (2022). The potential role of the epithelial cells and the mesenchymal stem cells in Crohn's disease fibrosis : from bedside to bench and back [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/290496 |
VIEUJEAN, S., LOLY, J.-P., BOUTAFFALA, L., MEUNIER, P., REENAERS, C., BRIQUET, A., LECHANTEUR, C., BAUDOUX, E., BEGUIN, Y., & LOUIS, E. (2022). Mesenchymal Stem Cell Injection in Crohn's Disease Strictures: a phase I-II clinical study. Journal of Crohn's and Colitis, 16, 506-510. doi:10.1093/ecco-jcc/jjab154 |
Monin, L., Dubois, S., REENAERS, C., VAN KEMSEKE, C., LATOUR, P., VAN DAELE, D., VIEUJEAN, S., SEIDEL, L., & Louis, E. (2021). Ustekinumab in bio-naïve and bio-failure Crohn's disease patients: Results from a « real-life » monocentric cohort. Digestive and Liver Disease. doi:10.1016/j.dld.2020.10.040 |
Pierre, N., Salée, C., Vieujean, S., Bequet, E., Merli, A.-M., Siegmund, B., Meuwis, M.-A., & Louis, E. (2021). Review article: distinctions between ileal and colonic Crohn's disease: from physiology to pathology. Alimentary Pharmacology and Therapeutics, 54 (6), 779-791. doi:10.1111/apt.16536 |
VIEUJEAN, S., MOENS, A., ROTHFUSS, K., SAVARINO, E., VAVRICKA, S., REENAERS, C., FERRANTE, M., & RAHIER, J.-F. (February 2019). Pneumocystis jirovecii pneumonia in IBD patients treated with immunomodulators [Poster presentation]. Belgian Week of Gastroenterology - 31th edition. |
VIEUJEAN, S., MOENS, A., ROTHFUSS, K., SAVARINO, E., VAVRICKA, S., REENAERS, C., FERRANTE, M., & RAHIER, J.-F. (February 2019). Pneumocystis jirovecii pneumonia in IBD patients treated with immunomodulator(s) [Poster presentation]. 14th Congress of ECCO. |
VIEUJEAN, S., LOUIS, E., & REENAERS, C. (February 2018). Immunosuppressive co-treatment with Infliximab and Adalimumab is not superior than anti-TNF monotherapy to prevent treatment failure over time in ulcerative colitis [Poster presentation]. 13th Congress of ECCO, Vienna, Austria. |
VIEUJEAN, S., LOUIS, E., & REENAERS, C. (February 2018). Immunosuppressive co-treatment with Infliximab and adalimumab is not superior than anti-TNF monotherapy to prevent treatment failure over time [Poster presentation]. 30th edition of Belgian Week of Gastroenterology. |
VIEUJEAN, S., LOUIS, E., & REENAERS, C. (February 2018). Étude dans la vie réelle de l’association d’un traitement immunosuppresseur avec l’Infliximab et l’Adalimumab dans la colite ulcéreuse [Poster presentation]. Journées Francophones d'Hépato-gastroentérologie et d'Oncologie Digestive. |
VIEUJEAN, S., LOUIS, E., & REENAERS, C. (October 2017). Immunosuppressive co-treatment with Infliximab and Adalimumab is not superior than anti-TNF monotherapy to prevent treatment failure over time in ulcerative colitis [Poster presentation]. 25th UEG week, Barcelona, Spain. |
VIEUJEAN, S., BRASSEUR, E., GHUYSEN, A., & D'ORIO, V. (17 January 2015). PROBLEMATIQUE DES LITS D’AVAL POUR LES ADMISSIONS VIA LES URGENCES [Poster presentation]. SYMPOSIUM OF THE BELGIAN SOCIETY OF EMERGENCY AND DISASTER MEDECINE, Bruxelles, Belgium. |